In 2018, Matousek et al. [16] concluded that regrowth was more likely in adenomas with higher expression levels of the p21 cell cycle marker, the p53 tumor suppressor marker and a higher Ki-67 proliferative index. The gene discussed is TP53; the disease is adenoma.